News

Comprehensive Overview on Celsius Holdings' Market Position

Comprehensive Overview on Celsius Holdings' Market Position

Morgan Stanley Maintains Equalweight Rating on Celsius Holdings

Morgan Stanley has reaffirmed its Equalweight rating for Celsius Holdings (NASDAQ: CELH), establishing a price target of $50.00. The firm's observations indicate a modest increase in sales, with a year-over-year sales growth of 5% noted in the two weeks ending October 5, 2024, across the Nielsen xAOC+C channels. While this growth may seem limited, it reflects a slight improvement in the average sales growth over the past two years.

According to recent data, Celsius's market share, excluding powdered products, has experienced a decline of 20 basis points sequentially to settle at 9.5%. This marks a decrease from the higher market share of 10.7% noted earlier in May. However, the total distribution points (TDP) for Celsius have remained stable with mid-30% growth, while the velocity of sales has shown a minor sequential improvement, even though it still reflects a year-over-year decline of low-20%.

Another notable trend is the sequential decrease in Celsius's promotional sales percentage, although it has increased when compared to last year. Additionally, the price/mix ratio has decreased by 3% in the last two weeks, an improvement over the 5% drop observed in the previous two weeks. Moreover, the sales metrics from Nielsen's new Full View Measurement dataset, incorporating 1P sales estimates from Amazon, suggest that Celsius's sales performance is on par with other channels, despite a lower implied share on Amazon compared to alternative sources.

Financial Forecasts and Market Insights

Morgan Stanley previously adjusted its projections for Celsius, downgrading third-quarter and full-year forecasts on September 4. The adjustments were attributed to PepsiCo's inventory reductions and overall softness in the beverage category, with an additional downgrade occurring on September 23 due to promotional accounting impacts linked to PepsiCo's inventory actions. The firm has emphasized the absence of a clear catalyst for Celsius until scanner data trends show positive movement.

Celsius Holdings recently disclosed a remarkable 23% rise in total revenue, achieving a record high of $402 million. International revenue reported a notable 30% increase to $19.6 million. However, the anticipated inventory reductions from PepsiCo are expected to have a significant impact on both sales and EBITDA for the upcoming third quarter and the full year of 2024. In light of these developments, various financial institutions, such as Piper Sandler, Jefferies, and Roth/MKM, have revised their price targets for Celsius Holdings, acknowledging the updated financial outlook. Piper Sandler has maintained its Overweight rating, reducing its price target from $50 to $47, while Jefferies and Roth/MKM set their targets at $48 and $43 respectively.

Strategic Board Changes and Growth Projections

Stifel financial services maintains a positive outlook for Celsius Holdings, indicating expectations for enhanced sales within convenience stores by 2025. This optimistic perspective coincides with recent significant changes within the company’s board, highlighted by the appointment of Hans Melotte—an experienced professional from Starbucks and Johnson & Johnson—who joins the board following Jim Lee's resignation.

Insights on Revenue Growth and Stock Performance

Recent InvestingPro insights underscore the context of Morgan Stanley's analysis concerning Celsius Holdings (NASDAQ: CELH). Despite noted slower growth, Celsius achieved impressive revenue growth of 56.5% over the last year, reaching a total of $1.49 billion. This robust financial performance is exhibited through a gross profit margin of 50.45% and an operating income margin of 22.42% during the same timeframe.

However, it is essential for investors to acknowledge that CELH's stock price has undergone notable volatility, with a decline of 33.84% over the past three months and a significant 52.62% drop over the last six months. This trend appears to resonate with Morgan Stanley's cautious viewpoint regarding the stock's near-term future.

Notably, Celsius is currently trading at a low P/E ratio in comparison to its expected earnings growth, highlighted by a PEG ratio of 0.13, which might suggest potential undervaluation given recent market challenges. Financially, the company is situated well, as it holds a greater amount of cash than debt on its balance sheet, indicating solid financial stability amid current uncertainties in the market.

Frequently Asked Questions

What is Morgan Stanley's rating for Celsius Holdings?

Morgan Stanley has maintained an Equalweight rating for Celsius Holdings with a price target of $50.00.

How did Celsius Holdings perform in terms of revenue?

Celsius Holdings reported a 23% increase in total revenue, reaching a record $402 million.

What challenges is Celsius facing regarding market share?

Celsius's market share, excluding powders, has declined to 9.5%, down from 10.7% earlier this year.

Are there any recent changes in Celsius's board of directors?

Yes, Hans Melotte from Starbucks and Johnson & Johnson recently joined the board after Jim Lee's resignation.

What financial outlook do analysts have for Celsius Holdings?

Several financial firms have revised their price targets for Celsius, with Piper Sandler reducing its target from $50 to $47 amid projected impacts from PepsiCo's inventory actions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 0

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 1

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 1

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 0

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 3

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 0

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading

Top 5 Most Recently Viewed Articles

Cohu's Strategic Market Entry Fuels Growth Amidst Challenges

Updated Category News Views 138

Cohu's Resilient Q3 Performance Highlights Cohu, Inc. (NASDAQ: COHU), a prominent supplier in semiconductor testing and inspection, recently reported its financial results for Q3 2024. The company's revenue stood at $95.3 million, reflecting a gross margin of 47%, showcasing a strong foundation with 67% of its revenue derived from recurring sources. This resilient...

Continue Reading
Prime Healthcare Achieves Remarkable Honors for Heart and Stroke Care

Updated Category News Views 108

Prime Healthcare's Dedication to Quality Care Prime Healthcare has recently celebrated a significant achievement, receiving recognition for its outstanding treatment of heart failure and strokes. The American Heart Association awarded 23 hospitals within the Prime Healthcare network with the prestigious Get With The Guidelines® - Heart Failure Award, highlighting their...

Continue Reading
Investigation of Endeavour Silver Corp. Claims by Pomerantz LLP

Updated Category News Views 44

Pomerantz LLP Investigates Claims Against Endeavour Silver Corp. Pomerantz LLP is actively investigating claims on behalf of investors in Endeavour Silver Corp. (NYSE: EXK). If you have invested in this company, it’s crucial to stay updated on recent developments and what they could mean for your investment. Details of the Investigation This investigation centers on...

Continue Reading
Exploring the Future of 5G Device Testing: Key Market Trends

Updated Category News Views 206

Growth and Developments in the 5G Device Testing Market The 5G Device Testing market has shown remarkable growth, with its expected value reaching USD 2.59 billion by 2032, up from USD 1.40 billion in 2023. This growth, estimated at a CAGR of 7.10%, reflects the increasing complexity of devices and the evolving standards governing connectivity and performance. As...

Continue Reading
Analyzing Short Interest Trends for CACI International Inc Shares

Updated Category News Views 152

Understanding Short Selling and Its Significance CACI International Inc's (NYSE: CACI) short interest as a percentage of floating shares has increased significantly. Recently, it was noted that the short interest has risen by 9.87%, with approximately 1.18 million shares sold short. This accounts for around 6.79% of all the shares available for trading on a regular basis....

Continue Reading